North Haven, CT, United States of America

Yunlong Zhang

This inventor holds 17 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 9 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Boehringer Ingelheim International Gmbh, Massachusetts Institute of Technology, Children's Medical Center Corporation. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yunlong Zhang. Retrieved from https://idiyas.com/inventor/yunlong-zhang-2qqeumt3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 9 (Patent Applications = 8)

Average Co-Inventor Count = 8.0

ph-index = 6

Forward Citations = 96(Granted Patents)

Location History:

Danbury, CT (US) (2012)
North Haven, CT (US) (2014 - 2016)
Valhalla, NY (US) (2018 - 2020)
Cambridge, MA (US) (2016 - 2022)

Company Filing History:

9 out of 1,564

Boehringer Ingelheim International Gmbh

patents

8 out of 8,600

Massachusetts Institute of Technology

patents

1 out of 1,076

Children's Medical Center Corporation

patents

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

Amino Acid Lipids

Peptide Lipids

Polypeptide Lipids

Aldosterone Inhibitors

Insulin Derivatives

Bicyclic Imidazole

Leukotriene Inhibitors

Heterocyclic Compounds

Rho Kinase Inhibitors

Urotensin II Antagonists

Fibrotic Diseases

Cardiovascular Treatments

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12648959 - Amino acid- , peptide- and polypeptide-lipids, isomers, compositions, and uses thereof (2026-06-09),

2. 11458158 - Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof (2022-10-04),

3. 10858342 - Bicyclic imidazole derivatives useful for the treatment of renal diseases, cardiovascular diseases and fibrotic diseases (2020-12-08),

4. 10682374 - Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof (2020-06-16),

5. 10086013 - Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof (2018-10-02),

6. 9890171 - Aldosterone synthase inhibitors (2018-02-13),

7. 9867869 - Insulin derivatives for diabetes treatment (2018-01-16),

8. 9512073 - Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof (2016-12-06),

9. 9439968 - Amine-containing lipidoids and uses thereof (2016-09-13),

10. 9403830 - Inhibitors of leukotriene production (2016-08-02),

11. 9334285 - Aldosterone synthase inhibitors (2016-05-10),

12. 9227917 - Amine-containing lipidoids and uses thereof (2016-01-05),

13. 9150577 - Heterocyclic compounds containing an indole core (2015-10-06),

14. 9079880 - Rho kinase inhibitors (2015-07-14),

15. 9073926 - Heterocyclic compounds containing a pyrrolopyridine or benzimidazole core (2015-07-07),

Title: Inventor Profile: Yunlong Zhang

Introduction

Yunlong Zhang is a prolific inventor based in North Haven, Connecticut, known for his groundbreaking contributions to the field of medicinal chemistry. With a notable portfolio of 16 patents, Zhang has developed innovative compounds and compositions that address critical health issues.

Latest Patents

Among his latest innovations, Zhang has created compounds referred to as amino acid-, peptide-, and polypeptide-lipids (APPLs). These compounds are characterized by the conjugation of lipophilic groups to amino or amide groups of specific biological structures, enhancing nucleotide delivery capabilities. His patent details various compounds, including those defined by specific formulas and their corresponding salts. Additionally, he has developed bicyclic imidazole derivatives aimed at treating renal, cardiovascular, and fibrotic diseases. These inventions provide pharmaceutical compositions and methods that are essential in the treatment of various disorders, showcasing Zhang's commitment to advancing healthcare solutions.

Career Highlights

Yunlong Zhang has had a distinguished career working at prominent organizations, including Boehringer Ingelheim International GmbH and the Massachusetts Institute of Technology (MIT). His roles at these institutions have allowed him to engage in innovative research and development, contributing significantly to the scientific community.

Collaborations

Throughout his career, Zhang has collaborated with leading figures in the field, including renowned researchers like Robert Samuel Langer and Daniel Griffith Anderson. These collaborations have further enriched his work, enhancing the impact of his inventions in the medicinal arena.

Conclusion

Yunlong Zhang stands out as a leading inventor whose work combines scientific innovation with practical applications in healthcare. His ongoing contributions continue to push the boundaries of medicinal chemistry, improving treatment options for patients around the world. As new challenges arise in medicine, Zhang's inventions will undoubtedly play a crucial role in shaping future solutions.

Profile summary based on public USPTO records.